Compare ZURA & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZURA | LPSN |
|---|---|---|
| Founded | 2022 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 84.5M |
| IPO Year | N/A | 2000 |
| Metric | ZURA | LPSN |
|---|---|---|
| Price | $3.99 | $5.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | ★ 359.1K | 221.0K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $257,660,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.97 | $4.47 |
| 52 Week High | $4.68 | $31.20 |
| Indicator | ZURA | LPSN |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 50.75 |
| Support Level | $3.58 | $4.63 |
| Resistance Level | $3.94 | $5.49 |
| Average True Range (ATR) | 0.24 | 0.30 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 95.69 | 50.86 |
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.